ALREX (Bausch & Lomb Incorporated)
Welcome to the PulseAid listing for the ALREX drug offered from Bausch & Lomb Incorporated. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bausch & Lomb Incorporated |
| NON-PROPRIETARY NAME: | loteprednol etabonate |
| SUBSTANCE NAME: | LOTEPREDNOL ETABONATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SUSPENSION/ DROPS |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1998-03-09 |
| END MARKETING DATE: | 0000-00-00 |
ALREX HUMAN PRESCRIPTION DRUG Details:
| Item Description | ALREX from Bausch & Lomb Incorporated |
| LABELER NAME: | Bausch & Lomb Incorporated |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2(mg/mL) |
| START MARKETING DATE: | 1998-03-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 24208-353_57c78944-babf-4e15-a3d9-b02bcd95ddae |
| PRODUCT NDC: | 24208-353 |
| APPLICATION NUMBER: | NDA020803 |
Other LOTEPREDNOL ETABONATE Pharmaceutical Manufacturers / Labelers:
